Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection

Among candidate drugs to treat coronavirus disease 2019 (COVID-19), the combination of hydroxychloroquine (HCQ) and azithromycin (AZ) has received intense worldwide attention. Even as the efficacy of this combination is under evaluation, clinicians have begun to use it largely. As these medications...

Descripción completa

Detalles Bibliográficos
Autores principales: Voisin, Olivier, Lorc’h, Erwan le, Mahé, Annabelle, Azria, Philippe, Borie, Marie-Françoise, Hubert, Sidonie, Ménage, Elodie, Guillerm, Jean-Christophe, Mourad, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mayo Foundation for Medical Education and Research 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237942/
https://www.ncbi.nlm.nih.gov/pubmed/32753141
http://dx.doi.org/10.1016/j.mayocp.2020.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237942/
https://www.ncbi.nlm.nih.gov/pubmed/32753141
http://dx.doi.org/10.1016/j.mayocp.2020.05.005

Ejemplares similares